Nonantibiotic Adjunctive Therapies for Community-Acquired Pneumonia (Corticosteroids and Beyond): Where Are We with Them?

Seminars in Respiratory and Critical Care Medicine

Volumn 37, Issue 6, 2016, Pages 913-922

  Sibila, Oriol ^a,b   Rodrigo Troyano, Ana ^a,b   Torres, Antoni ^c,d  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

community acquired pneumonia; corticosteroids; immunoglobulins; statins

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN;

ADJUVANT THERAPY; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL OUTCOME; COMMUNITY ACQUIRED PNEUMONIA; CORTICOSTEROID THERAPY; DRUG MECHANISM; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; META ANALYSIS (TOPIC); MORTALITY; MULTICENTER STUDY (TOPIC); NONHUMAN; OBSERVATIONAL STUDY; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STEM CELL TRANSPLANTATION; SYSTEMATIC REVIEW (TOPIC); COMMUNITY ACQUIRED INFECTION; HOSPITALIZATION; MESENCHYMAL STEM CELL TRANSPLANTATION; PNEUMONIA; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; COMMUNITY-ACQUIRED INFECTIONS; HOSPITALIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOGLOBULINS; MESENCHYMAL STEM CELL TRANSPLANTATION; PNEUMONIA; TREATMENT OUTCOME;

EID: 85006377308     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0036-1593538     Document Type: Article

References (74)

1. Jemal A Ward E Hao Y Thun M Trends in the leading causes of death in the United States, 1970-2002 JAMA 2005 294 10 1255 1259
2. Murray C J Lopez A D Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study Lancet 1997 349 9064 1498 1504
3. Heron M Hoyert D L Murphy S L Xu J Kochanek K D Tejada-Vera B Deaths: final data for 2006 Natl Vital Stat Rep 2009 57 14 1 134
4. Shindo Y Ito R Kobayashi D, et al; Central Japan Lung Study Group. Risk factors for 30-day mortality in patients with pneumonia who receive appropriate initial antibiotics: an observational cohort study Lancet Infect Dis 2015 15 9 1055 1065
5. Rittirsch D Flierl M A Ward P A Harmful molecular mechanisms in sepsis Nat Rev Immunol 2008 8 10 776 787
6. Kellum J A Kong L Fink M P, et al; GenIMS Investigators. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study Arch Intern Med 2007 167 15 1655 1663
7. Yende S D'Angelo G Kellum J A, et al; GenIMS Investigators. Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis Am J Respir Crit Care Med 2008 177 11 1242 1247
8. Wunderink R G Adjunctive therapy in community-acquired pneumonia Semin Respir Crit Care Med 2009 30 2 146 153
9. Montón C Ewig S Torres A, et al. Role of glucocorticoids on inflammatory response in nonimmunosuppressed patients with pneumonia: a pilot study Eur Respir J 1999 14 1 218 220
10. Sibila O Ferrer M Agustí C Torres A Corticosteroids as adjunctive treatment in community-acquired pneumonia Minerva Anestesiol 2014 80 12 1336 1344
11. Rhen T Cidlowski J A Antiinflammatory action of glucocorticoids - new mechanisms for old drugs N Engl J Med 2005 353 16 1711 1723
12. Webster J I Tonelli L Sternberg E M Neuroendocrine regulation of immunity Annu Rev Immunol 2002 20 125 163
13. Baldwin A S Jr Series introduction: the transcription factor NF-kappaB and human disease J Clin Invest 2001 107 1 3 6
14. Edwards M R Bartlett N W Clarke D Birrell M Belvisi M Johnston S L Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease Pharmacol Ther 2009 121 1 1 13
15. Sibila O Luna C M Agustí C, et al. Effects of glucocorticoids in ventilated piglets with severe pneumonia Eur Respir J 2008 32 4 1037 1046
16. Meduri G U Kanangat S Bronze M, et al. Effects of methylprednisolone on intracellular bacterial growth Clin Diagn Lab Immunol 2001 8 6 1156 1163
17. Li Y Cui X Li X, et al. Risk of death does not alter the efficacy of hydrocortisone therapy in a mouse E. coli pneumonia model: risk and corticosteroids in sepsis Intensive Care Med 2008 34 3 568 577
18. Tagliabue C Salvatore C M Techasaensiri C, et al. The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection J Infect Dis 2008 198 8 1180 1188
19. Menéndez R Cavalcanti M Reyes S, et al. Markers of treatment failure in hospitalised community acquired pneumonia Thorax 2008 63 5 447 452
20. Ramírez P Ferrer M Martí V, et al. Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia Crit Care Med 2011 39 10 2211 2217
21. Menéndez R Martínez R Reyes S, et al. Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia Thorax 2009 64 7 587 591
22. Garcia-Vidal C Calbo E Pascual V Ferrer C Quintana S Garau J Effects of systemic steroids in patients with severe community-acquired pneumonia Eur Respir J 2007 30 5 951 956
23. Salluh J IF Soares M Coelho L M, et al. Impact of systemic corticosteroids on the clinical course and outcomes of patients with severe community-acquired pneumonia: a cohort study J Crit Care 2011 26 2 193 200
24. Tagami T Matsui H Horiguchi H Fushimi K Yasunaga H Low-dose corticosteroid use and mortality in severe community-acquired pneumonia patients Eur Respir J 2015 45 2 463 472
25. Confalonieri M Urbino R Potena A, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study Am J Respir Crit Care Med 2005 171 3 242 248
26. Snijders D Daniels J MA de Graaff C S van der Werf T S Boersma W G Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial Am J Respir Crit Care Med 2010 181 9 975 982
27. Meijvis S CA Hardeman H Remmelts H HF, et al. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial Lancet 2011 377 9782 2023 2030
28. Fernández-Serrano S Dorca J Garcia-Vidal C, et al. Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial Crit Care 2011 15 2 R96
29. Torres A Sibila O Ferrer M, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial JAMA 2015 313 7 677 686
30. Blum C A Nigro N Briel M, et al. Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial Lancet 2015 385 9977 1511 1518
31. Chen Y Li K Pu H Wu T Corticosteroids for pneumonia Cochrane Database Syst Rev 2011 3 CD007720
32. Nie W Zhang Y Cheng J Xiu Q Corticosteroids in the treatment of community-acquired pneumonia in adults: a meta-analysis PLoS ONE 2012 7 10 e47926
33. Marti C Grosgurin O Harbarth S, et al. Adjunctive corticotherapy for community acquired pneumonia: a systematic review and meta-analysis PLoS ONE 2015 10 12 e0144032
34. Wan Y-D Sun T-W Liu Z-Q Zhang S-G Wang L-X Kan Q-C Efficacy and safety of corticosteroids for community-acquired pneumonia: a systematic review and meta-analysis Chest 2016 149 1 209 219
35. Siemieniuk R AC Meade M O Alonso-Coello P, et al. Corticosteroid therapy for patients hospitalized with community-acquired pneumonia: a systematic review and meta-analysis Ann Intern Med 2015 163 7 519 528
36. Baigent C Keech A Kearney P M, et al; Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 2005 366 9493 1267 1278
37. Hou W Lv J Perkovic V, et al. Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis Eur Heart J 2013 34 24 1807 1817
38. Gutierrez J Ramirez G Rundek T Sacco R L Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis Arch Intern Med 2012 172 12 909 919
39. Blanco-Colio L M Tuñón J Martín-Ventura J L Egido J Anti-inflammatory and immunomodulatory effects of statins Kidney Int 2003 63 1 12 23
40. Ascer E Bertolami M C Venturinelli M L, et al. Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients Atherosclerosis 2004 177 1 161 166
41. Novack V Eisinger M Frenkel A, et al. The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial Intensive Care Med 2009 35 7 1255 1260
42. Almog Y Shefer A Novack V, et al. Prior statin therapy is associated with a decreased rate of severe sepsis Circulation 2004 110 7 880 885
43. Merx M W Liehn E A Graf J, et al. Statin treatment after onset of sepsis in a murine model improves survival Circulation 2005 112 1 117 124
44. Jerwood S Cohen J Unexpected antimicrobial effect of statins J Antimicrob Chemother 2008 61 2 362 364
45. van de Garde E MW Hak E Souverein P C Hoes A W van den Bosch J M Leufkens H G Statin treatment and reduced risk of pneumonia in patients with diabetes Thorax 2006 61 11 957 961
46. Chung S-D Tsai M-C Lin H-C Kang J-H Statin use and clinical outcomes among pneumonia patients Clin Microbiol Infect 2014 20 9 879 885
47. Polgreen L A Cook E A Brooks J M Tang Y Polgreen P M Increased statin prescribing does not lower pneumonia risk Clin Infect Dis 2015 60 12 1760 1766
48. Makris D Manoulakas E Komnos A, et al. Effect of pravastatin on the frequency of ventilator-associated pneumonia and on intensive care unit mortality: open-label, randomized study Crit Care Med 2011 39 11 2440 2446
49. Papazian L Roch A Charles P-E, et al; STATIN-VAP Study Group. Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial JAMA 2013 310 16 1692 1700
50. Viasus D Garcia-Vidal C Simonetti A F, et al. The effect of simvastatin on inflammatory cytokines in community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial BMJ Open 2015 5 1 e006251
51. Kreymann K G de Heer G Nierhaus A Kluge S Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock Crit Care Med 2007 35 12 2677 2685
52. Taccone F S Stordeur P De Backer D Creteur J Vincent J-L Gamma-globulin levels in patients with community-acquired septic shock Shock 2009 32 4 379 385
53. de la Torre M C Bolíbar I Vendrell M, et al. Serum immunoglobulins in the infected and convalescent phases in community-acquired pneumonia Respir Med 2013 107 12 2038 2045
54. Shankar-Hari M Spencer J Sewell W A Rowan K M Singer M Bench-to-bedside review: immunoglobulin therapy for sepsis-biological plausibility from a critical care perspective Crit Care 2012 16 2 206
55. Werdan K Pilz G Bujdoso O, et al; Score-Based Immunoglobulin Therapy of Sepsis (SBITS) Study Group. Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study Crit Care Med 2007 35 12 2693 2701
56. Alejandria M M Lansang M AD Dans L F Mantaring J B III Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock Cochrane Database Syst Rev 2013 9 CD001090
57. Welte T Dellinger R P Ebelt H, et al. Concept for a study design in patients with severe community-acquired pneumonia: a randomised controlled trial with a novel IGM-enriched immunoglobulin preparation-the CIGMA study Respir Med 2015 109 6 758 767
58. Gupta N Krasnodembskaya A Kapetanaki M, et al. Mesenchymal stem cells enhance survival and bacterial clearance in murine Escherichia coli pneumonia Thorax 2012 67 6 533 539
59. Asmussen S Ito H Traber D L, et al. Human mesenchymal stem cells reduce the severity of acute lung injury in a sheep model of bacterial pneumonia Thorax 2014 69 9 819 825
60. Hackstein H Lippitsch A Krug P, et al. Prospectively defined murine mesenchymal stem cells inhibit Klebsiella pneumoniae-induced acute lung injury and improve pneumonia survival Respir Res 2015 16 123
61. Marik P Kraus P Sribante J Havlik I Lipman J Johnson D W Hydrocortisone and tumor necrosis factor in severe community-acquired pneumonia. A randomized controlled study Chest 1993 104 2 389 392
62. McHardy V U Schonell M E Ampicillin dosage and use of prednisolone in treatment of pneumonia: co-operative controlled trial BMJ 1972 4 5840 569 573
63. Mikami K Suzuki M Kitagawa H, et al. Efficacy of corticosteroids in the treatment of community-acquired pneumonia requiring hospitalization Lung 2007 185 5 249 255
64. van Woensel J BM van Aalderen W MC de Weerd W, et al. Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus Thorax 2003 58 5 383 387
65. Cao L F Lu Y M Ma H G Ma M Budesonide inhaling auxiliary therapy after mycoplasma pneumoniae infection of children Int J Respir 2007 27 8 567-569
66. Wagner H N Jr Bennett I L Jr Lasagna L Cluff L E Rosenthal M B Mirick G S The effect of hydrocortisone upon the course of pneumococcal pneumonia treated with penicillin Bull Johns Hopkins Hosp 1956 98 3 197 215
67. Sabry N Omar E Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings Pharmacol Pharm 2011 2 73 81
68. Bennett I L Findland M Hamburger M Kass E Lepper M Waisbren B The effectiveness of hydrocortisone in the management of severe infections JAMA 1963 183 6 462 465
69. Klastersky J Cappel R Debusscher L Effectiveness of betamethasone in management of severe infections. A double-blind study N Engl J Med 1971 284 22 1248 1250
70. Nafae R M Ragab M I Amany F M Rashed S B Adjuvant role of corticosteroids in the treatment of community-acquired pneumonia Egypt J Chest Dis Tuberc 2013 62 3 439 445
71. El Ghamrawy A Shokeir M Esmat A Effects of low dose hydrocortisone in ICU patients with severe community acquired pneumonia Egypt J Chest Dis Tuberc 2006 5 91 99
72. Chon G R Lim C-M Koh Y Hong S-B Analysis of systemic corticosteroid usage and survival in patients requiring mechanical ventilation for severe community-acquired pneumonia J Infect Chemother 2011 17 4 449 455
73. Ugajin M Yamaki K Hirasawa N Kobayashi T Yagi T Impact and indication of early systemic corticosteroids for very severe community-acquired pneumonia Int J Gen Med 2013 6 693 701
74. Polverino E Cillóniz C Dambrava P, et al. Systemic corticosteroids for community-acquired pneumonia: reasons for use and lack of benefit on outcome Respirology 2013 18 2 263 271